Alvotech (ALVO)
14.00
+0.06
(+0.43%)
USD |
NASDAQ |
May 22, 16:00
14.01
+0.01
(+0.07%)
After-Hours: 20:00
Alvotech Free Cash Flow: -338.67M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -338.67M |
| December 31, 2023 | -358.66M |
| September 30, 2023 | -355.88M |
| Date | Value |
|---|---|
| June 30, 2023 | -346.63M |
| March 31, 2023 | -410.62M |
| December 31, 2022 | -361.39M |
Free Cash Flow Range, Past 5 Years
-410.62M
Minimum
Mar 2023
-338.67M
Maximum
Mar 2024
-361.97M
Average
-357.27M
Median
Free Cash Flow Benchmarks
| AbbVie Inc | 21.89B |
| Teva Pharmaceutical Industries Ltd | 878.00M |
| Moolec Science SA | -12.79M |
| Procaps Group SA | 34.06M |
| NeuroMetrix Inc | -7.045M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -75.40M |
| Cash from Investing (Quarterly) | -3.48M |
| Cash from Financing (Quarterly) | 133.18M |
| Free Cash Flow Per Share (Quarterly) | -0.3256 |
| Free Cash Flow to Equity (Quarterly) | -98.00M |
| Free Cash Flow to Firm (Quarterly) | 98.02M |
| Free Cash Flow Yield | -9.95% |